Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antisense Therapeutics reports data from phase I trial of ATL-1102

July 24, 2014

No Comments

AOP Orphan conducting new trial in polycythemia vera

July 24, 2014

No Comments

Cadila Healthcare patents novel HIF prolyl-hydroxylase inhibitors

July 21, 2014

No Comments

Rigel advances fostamatinib into phase III for ITP

July 21, 2014

No Comments

FDA approves Ruconest for acute angioedema attacks

July 17, 2014

No Comments

Lilly discloses new anti-BMP-6 MAbs

July 17, 2014

No Comments

Portola Pharmaceuticals and Daiichi Sankyo form second collaboration

July 9, 2014

No Comments

FDA approves NovoSeven RT for Glanzmann's thrombasthenia

July 8, 2014

No Comments

Xenetic Biosciences reports safety data from ongoing phase II study of ErepoXen

July 2, 2014

No Comments

FDA grants small business waver of PDUFA fee for Rockwell's Triferic

July 2, 2014

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Antisense Therapeutics reports data from phase I trial of ATL-1102

AOP Orphan conducting new trial in polycythemia vera

Cadila Healthcare patents novel HIF prolyl-hydroxylase inhibitors

Rigel advances fostamatinib into phase III for ITP

FDA approves Ruconest for acute angioedema attacks

Lilly discloses new anti-BMP-6 MAbs

Portola Pharmaceuticals and Daiichi Sankyo form second collaboration

FDA approves NovoSeven RT for Glanzmann's thrombasthenia

Xenetic Biosciences reports safety data from ongoing phase II study of ErepoXen

FDA grants small business waver of PDUFA fee for Rockwell's Triferic

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Hematologic RSS

Hematologic
RSS